title: Tc99m-sestamibi uptake in osteitis fibrosa cystica simulating metastatic bone disease.
authors.affiliation: Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
authors.forename: M R
authors.initials: MR
authors.lastname: Rubin
authors.forename: V A
authors.initials: VA
authors.lastname: Livolsi
authors.forename: F
authors.initials: F
authors.lastname: Bandeira
authors.forename: G
authors.initials: G
authors.lastname: Caldas
authors.forename: J P
authors.initials: JP
authors.lastname: Bilezikian
mesh_terms: D000328:Adult; D019386:Alendronate / Q000627:therapeutic use; D015415:Biomarkers; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D003937:Diagnosis, Differential; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D010002:Osteitis Fibrosa Cystica / Q000000981:diagnostic imaging* / Q000378:metabolism; D010281:Parathyroid Hormone / Q000627:therapeutic use; D010282:Parathyroid Neoplasms / Q000473:pathology / Q000601:surgery; D016105:Parathyroidectomy; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D017256:Technetium Tc 99m Sestamibi / Q000493:pharmacokinetics
chemical_list: D015415:Biomarkers; D010281:Parathyroid Hormone; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D019386:Alendronate